This is the authors' abstract. We don't add key points for this paper.
We found that secondary erythrocytosis can be related to variants in EPO that lead to the production of hepatic-like EPO with an atypical glycosylation pattern and increased activity. (Funded by Région des Pays de la Loire and others; ClinicalTrials.gov number, NCT03957863.).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: